Tumour Versus Germline

BRCA1 BRCA2 NGS PARP carcinoma ovarian service somatic tumour

Journal

Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402

Informations de publication

Date de publication:
19 Mar 2021
Historique:
received: 01 03 2021
accepted: 17 03 2021
entrez: 3 4 2021
pubmed: 4 4 2021
medline: 4 4 2021
Statut: epublish

Résumé

The aim of this audit was to evaluate the usefulness and serviceability of testing for pathogenic mutations in

Identifiants

pubmed: 33808557
pii: diagnostics11030547
doi: 10.3390/diagnostics11030547
pmc: PMC8003427
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Int J Gynecol Cancer. 2021 Feb;31(2):272-278
pubmed: 33468564
J Clin Oncol. 2012 Jul 20;30(21):2654-63
pubmed: 22711857
N Engl J Med. 2016 Dec;375(22):2154-2164
pubmed: 27717299
Virchows Arch. 2017 Oct;471(4):491-500
pubmed: 28812131
Cancers (Basel). 2020 Nov 21;12(11):
pubmed: 33233347
BMC Cancer. 2019 Apr 2;19(1):296
pubmed: 30940100
Gynecol Oncol. 2020 Sep;158(3):747-753
pubmed: 32674931
J Natl Cancer Inst. 2002 Jan 2;94(1):61-7
pubmed: 11773283
Nature. 2008 Feb 28;451(7182):1111-5
pubmed: 18264088
N Engl J Med. 2018 Dec 27;379(26):2495-2505
pubmed: 30345884
Sci Rep. 2016 Jul 13;6:29506
pubmed: 27406733
Science. 1994 Oct 7;266(5182):66-71
pubmed: 7545954
J Med Genet. 2019 Mar;56(3):195-198
pubmed: 29535157
Ann Oncol. 2015 Oct;26(10):2057-65
pubmed: 26153499
J Clin Oncol. 2011 Aug 1;29(22):3008-15
pubmed: 21709188
Lancet. 2017 Oct 28;390(10106):1949-1961
pubmed: 28916367
Nature. 2011 Jun 29;474(7353):609-15
pubmed: 21720365
JAMA. 2012 Jan 25;307(4):382-90
pubmed: 22274685
J Med Genet. 2016 Oct;53(10):655-61
pubmed: 27208206
Cancer Sci. 2004 Nov;95(11):866-71
pubmed: 15546503
Am J Surg Pathol. 2010 Mar;34(3):433-43
pubmed: 20154587
JAMA. 2017 Sep 5;318(9):825-835
pubmed: 28873162
Nature. 1995 Dec 21-28;378(6559):789-92
pubmed: 8524414
PLoS One. 2013;8(3):e58182
pubmed: 23536787
J Natl Cancer Inst. 2020 Feb 1;112(2):161-169
pubmed: 31076742
N Engl J Med. 2019 Dec 19;381(25):2391-2402
pubmed: 31562799
Cancers (Basel). 2019 Oct 24;11(11):
pubmed: 31653094

Auteurs

Iolia Akaev (I)

School of Pharmacy and Biomedical Sciences, University of Portsmouth, St. Michaels Building, White Swan Road, Portsmouth PO1 2DT, UK.

Siavash Rahimi (S)

School of Pharmacy and Biomedical Sciences, University of Portsmouth, St. Michaels Building, White Swan Road, Portsmouth PO1 2DT, UK.
Department of Histopathology, Brighton and Sussex University Hospitals NHS Trust, Royal Sussex County Hospital, Brighton BN2 5BE, UK.

Olubukola Onifade (O)

Department of Cellular Pathology, Portsmouth Hospitals University NHS Trust, Southwick Hill Road, Portsmouth PO6 3LY, UK.

Francis John Edward Gardner (FJE)

Department of Obstetrics and Gynaecology, Portsmouth Hospitals University NHS Trust, Southwick Hill Road, Portsmouth PO6 3LY, UK.

David Castells-Rufas (D)

Microelectronics and Electronic Systems Department, Universitat Autònoma de Barcelona, Carrer de les Sitges s/n, 08193 Bellaterra, Spain.

Eleanor Jones (E)

Department of Oncology, Portsmouth Hospitals University NHS Trust, Southwick Hill Road, Portsmouth PO6 3LY, UK.

Shyamika Acharige (S)

Department of Oncology, Portsmouth Hospitals University NHS Trust, Southwick Hill Road, Portsmouth PO6 3LY, UK.

Chit Cheng Yeoh (CC)

Department of Oncology, Portsmouth Hospitals University NHS Trust, Southwick Hill Road, Portsmouth PO6 3LY, UK.

Classifications MeSH